|
LRH-1 antagonist
|
CHEBI_136580 |
|
|
disease of anatomical entity
|
DOID_7 |
|
|
U87-EGFRvIII cell
|
CLO_0037276 |
|
|
compound fluorescence assay
|
BAO_0001099 |
|
|
artifact assay
|
BAO_0000684 |
|
|
alternate assay conditions
|
BAO_0001098 |
|
|
alternate confirmatory assay
|
BAO_0000806 |
|
|
TMD8 cell
|
CLO_0037272 |
|
|
alternate assay type
|
BAO_0001097 |
|
|
orthogonal assay technology
|
BAO_0001096 |
|
|
EC 1.7.* (oxidoreductase acting on other nitrogenous compounds as donors) inhibitor
|
CHEBI_76734 |
|
|
EC 1.6.* (oxidoreductase acting on NADH or NADPH) inhibitor
|
CHEBI_76733 |
|
|
EC 1.9.* (oxidoreductase acting on donor heme group) inhibitor
|
CHEBI_76736 |
|
|
EC 1.8.* (oxidoreductase acting on sulfur group of donors) inhibitor
|
CHEBI_76735 |
|
|
EC 1.11.* (oxidoreductase acting on peroxide as donors) inhibitor
|
CHEBI_76738 |
|
|
EC 1.10.* (oxidoreductase acting on diphenols and related substances as donors) inhibitor
|
CHEBI_76737 |
|
|
EC 1.12.* (oxidoreductase acting on hydrogen as donors) inhibitor
|
CHEBI_76739 |
|
|
EC 1.13.* [oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases)] inhibitor
|
CHEBI_76740 |
|
|
photoallergic dermatitis
|
DOID_3818 |
|
|
EC 1.16.* (oxidoreductase oxidising metal ions) inhibitor
|
CHEBI_76743 |
|
